Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Pierre Thadee Victor Kemula

CFO at AgomAb Therapeutics NV (AGMB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$5K
Total bought / sold$86K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 7SEC AGMBAgomAb Therapeutics NV Buy 3,000new position $8.67 $26K +4.7%
Oct 7SEC AGMBAgomAb Therapeutics NV Buy 5,0008,000 held (+167%) $8.57 $43K +6.0%
Oct 7SEC AGMBAgomAb Therapeutics NV Buy 2,00010,000 held (+25%) $8.54 $17K +6.3%
  • Buy

    CFO Pierre Thadee Victor Kemula bought $26K of AGMB at $8.67 — first open-market purchase in our records; opens a new position.

  • Buy

    CFO Pierre Thadee Victor Kemula bought $43K of AGMB at $8.57 — largest purchase by this insider in our records; raises the stake by 167%.

  • Buy

    CFO Pierre Thadee Victor Kemula bought $17K of AGMB at $8.54 — raises the stake by 25%.